scout

Sumit K. Subudhi, MD, PhD

Articles by Sumit K. Subudhi, MD, PhD

Expert on prostate cancer

CAR T-Cell Therapy in Metastatic CRPC and Future Directions in Care

ByRana R. McKay, MD, University of California San Diego Medical Center,Arash Rezazadeh Kalebasty, MD ,Sumit K. Subudhi, MD, PhD,Scott T. Tagawa, MD, MS, FACP, New York-Presbyterian Hospital & Weill Cornell Medical College,Ulka Vaishampayan, MD

Closing out their final module, expert panelists consider the role of CAR T-cell therapy in metastatic castration-resistant prostate cancer and look toward future evolutions in the broader treatment landscape.

Experts on prostate cancer

Combination PARPi Strategies in Metastatic CRPC: Interpreting Data From Clinical Trials

ByRana R. McKay, MD, University of California, San Diego,Arash Rezazadeh Kalebasty, MD ,Sumit K. Subudhi, MD, PhD,Scott T. Tagawa, MD, MS, FACP, New York-Presbyterian Hospital & Weill Cornell Medical College,Ulka Vaishampayan, MD

Key opinion leaders in metastatic castration-resistant prostate cancer management review a subset of clinical trials focused on combination strategies with PARP inhibitors.

Experts on prostate cancer

Overview of Metastatic HSPC: Diagnosis and Risk Stratification

ByRana R. McKay, MD, University of California San Diego Medical Center,Sumit K. Subudhi, MD, PhD,Scott T. Tagawa, MD, MS, FACP, New York-Presbyterian Hospital & Weill Cornell Medical College,Ulka Vaishampayan, MD,Arash Rezazadeh Kalebasty, MD

Opening their first module on metastatic hormone-sensitive prostate cancer, panelists consider optimal diagnostic and risk stratification strategies for when a patient presents in clinic.

Latest Updated Articles